
浏览全部资源
扫码关注微信
中国中医科学院广安门医院泌尿科,北京 100053
朱 赫,Email:zhuhe0566@sina.com,研究方向:泌尿系统疾病的中西医结合诊疗。
卢建新,Email:13501392760@163.com。
收稿:2023-05-30,
修回:2023-06-28,
录用:2023-07-06,
纸质出版:2023-08-28
移动端阅览
朱赫,庞然,卢建新.肌层浸润性膀胱癌的中西医结合保留膀胱治疗[J].重庆医科大学学报,2023,48(8):875-879.
Zhu He,Pang Ran,Lu Jianxin.Treatment of muscle invasive bladder cancer with bladder preservation combined with traditional Chinese and western medicine[J].Journal of Chongqing Medical University,2023,48(8):875-879.
朱赫,庞然,卢建新.肌层浸润性膀胱癌的中西医结合保留膀胱治疗[J].重庆医科大学学报,2023,48(8):875-879. DOI: 10.13406/j.cnki.cyxb.003293.
Zhu He,Pang Ran,Lu Jianxin.Treatment of muscle invasive bladder cancer with bladder preservation combined with traditional Chinese and western medicine[J].Journal of Chongqing Medical University,2023,48(8):875-879. DOI: 10.13406/j.cnki.cyxb.003293.
目的
2
探寻无法接受根治性手术治疗及放化疗的肌层浸润性膀胱癌病例的有效辅助治疗方式。
方法
2
回顾性分析近10年广安门医院泌尿科肌层浸润性膀胱癌出院病例,统计患者治疗方式及保留膀胱时间。
结果
2
61.90%应用膀胱肿瘤介入栓塞联合经尿道膀胱肿瘤切除术及中药治疗的患者达到了保留膀胱时间大于3年的治疗效果。
结论
2
应用中西医结合治疗方式可能辅助延长肌层浸润性膀胱癌患者保留膀胱时间,改善患者预后及生存质量。
Objective
2
To explore an effective adjuvant therapy for patients with muscle invasive bladder cancer who cannot accept radical surgery,radiotherapy,and chemotherapy.
Methods
2
A retrospective analysis was conducted on patients with muscle invasive bladder cancer discharged from the Department of Urology of Guang’anmen Hospital in the past 10 years. The treatment methods and bladder retention time were analyzed.
Results
2
Of patients treated with bladder tumor interventional embolization combined with transurethral bladder tumor resection and traditional Chinese medicine,61.90% patients achieved a treatment effect of retaining the bladder for more than 3 years.
Conclusion
2
The application of integrated traditional Chinese and Western medicine may help prolong the bladder retention time of patients with muscle invasive bladder cancer and improve the prognosis and quality of life of patients.
Efstathiou JA , Spiegel DY , Shipley WU , et al . Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience [J ] . European Urology , 2012 , 61 ( 4 ): 705 - 711 .
郭晋锋 , 席俊峰 , 任连生 , 等 . 苏复宁洗液膀胱灌注治疗膀胱癌的疗效观察 [J ] . 中国药物与临床 , 2021 , 21 ( 1 ): 120 - 121 .
Guo JF , Xi JF , Ren LS , et al . Observation on the effect of Sufuning lotion intravesical instillation in the treatment of bladder cancer [J ] . Chinese Remedies & Clinics , 2021 , 21 ( 1 ): 120 - 121 .
徐 豪 , 石红林 , 郝建伟 , 等 . 紫花牡荆素通过抑制7次跨膜超蛋白家族成员4的表达抑制膀胱癌细胞增殖迁移和侵袭 [J ] . 中华肿瘤杂志 , 2022 , 44 ( 4 ): 334 - 340 .
Xu H , Shi HL , Hao JW , et al . Cerexin inhibits the proliferation,migration and invasion of bladder cancer cells by inhibition of TM7SF4 expression [J ] . Chinese Journal of Oncology , 2022 , 44 ( 4 ): 334 - 340 .
郭鹏荣 , 盛玉文 , 刘 奔 , 等 . 灵芝多糖对顺铂抑制荷膀胱癌T24细胞裸鼠肿瘤生长及血管生成作用的影响 [J ] . 解放军医学杂志 , 2014 , 39 ( 6 ): 470 - 474 .
Guo PR , Sheng YW , Liu B , et al . Influence of Ganoderma lucidum polysaccharide on the inhibitory effects of cisplatin on the tumor growth and angiogenesis in bladder cancer(T24) cells-bearing nude mice [J ] . Med J Chin PLA , 2014 , 39 ( 6 ): 470 - 474 .
张亚强 , 宋竖旗 , 李克刚 , 等 . 中药联合膀胱灌注预防非肌层浸润性膀胱癌术后复发疗效观察 [J ] . 中医肿瘤学杂志 , 2020 , 2 ( 4 ): 19 - 22 .
Zhang YQ , Song SQ , Li KG , et al . Clinical study on prevention of postoperative recurrence of non-muscle invasive bladder cancer by Chinese medicine combined with intravesical instillation [J ] . Journal of Oncology in Chinese Medicine , 2020 , 2 ( 4 ): 19 - 22 .
Fahmy O , Khairul-Asri MG , Schubert T , et al . A systematic review and Meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer [J ] . Urol Oncol , 2018 , 36 ( 2 ): 43 - 53 .
0
浏览量
15
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621